Neurofibromatosis: analysis of clinical cases and new diagnostic criteria
Open Access
- 14 February 2022
- journal article
- review article
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 12 (1) , 39-48
Abstract
Neurofibromatoses are a group of genetic disorders with predisposing for central and peripheral nervous system tumor development. The group includes three entities: neurofibromatosis type I, neurofibromatosis type II and schwannomatosis, which are characterized by gradual phenotype development and have a partially overlapping spectrum of manifestations, which complicates diagnosis establishing, especially at the stage of clinical onset. At the same time, the emergence of new pathogenetic therapy and the high risk of transmission to descendants actualize the necessity of early diagnosis. DNA tests allow us to reliably confirm the presumed diagnosis. This article presents a review of neurofibromatoses, their clinical features and courses, modern diagnostic criteria and indications for DNA tests.Keywords
This publication has 51 references indexed in Scilit:
- Neurofibromatosis type 22015
- p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromasEuropean Journal of Human Genetics, 2014
- Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1The Journal of Dermatology, 2014
- Characterization of early onset neurofibromatosis type 2Brain and Development, 2014
- Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteriaAmerican Journal of Medical Genetics Part A, 2013
- Neurofibromatoses2012
- Empirical development of improved diagnostic criteria for neurofibromatosis 2Genetics in Medicine, 2011
- Molecular Dissection of Isolated Disease Features in Mosaic Neurofibromatosis Type 1The American Journal of Human Genetics, 2007
- Diagnostic criteria for schwannomatosisNeurology, 2005
- NeurofibromatosisArchives of Neurology, 1988